▶ Полный текст поста
The game is finding asymmetric moves before the market fully prices them in. INFQ checks several boxes that IonQ (IONQ), D-Wave (QBTS), and Rigetti (RGTI) currently don’t stack up as cleanly on.
1. Fresh IPO, Small Market Cap — Maximum Catalyst Sensitivity
Infleqtion went public on February 17, 2026, raising over $550 million in gross proceeds.  That’s a relatively recent listing, which means the options market hasn’t had years to “find” a fair IV baseline. IonQ’s market cap is more than six times larger than Infleqtion’s , meaning any given dollar of news has a disproportionately larger price impact on INFQ. Smaller float = larger percentage swings = higher option premiums and bigger payoffs on directional plays when news hits.
2. Government Catalyst Is Right Now, Not Speculative
This is the most important timing factor. The U.S. government is rolling out a $2 billion quantum-computing grant program with minority equity stakes, and Infleqtion is expected to be one of only nine quantum players in that elite pool.  Even more specifically, a proposed $100 million award tied to the CHIPS and Science Act would help Infleqtion expand quantum hardware and U.S. manufacturing  — and for a company doing under $10M per quarter in revenue, that’s transformative on the balance sheet.
The catalyst isn’t vague future adoption — it’s federal money with a named award. That’s the kind of defined binary event options are built for.
3. Volatility Profile is Asymmetric vs. Peers
INFQ’s balance sheet is cash-rich, with roughly $443.54 million in cash and short-term investments and minimal long-term debt at about $3.81 million, while posting a net loss of $30.26 million in Q1 2026.  That combination — big cash runway, steep losses, and major incoming catalysts — is exactly the setup that produces explosive headline-driven moves.
INFQ saw a premarket 35% spike recently as news around the CHIPS Act funding hit.  Today alone, it’s up another 9.5% on partnership news. Those are the kinds of moves that can turn a call position into a multi-bagger in 24–48 hours.
4. Technology Differentiation Sets It Apart from the Crowded Trade
Infleqtion is the first pure-play quantum computing company using neutral-atom technology to go public. Its approach employs atoms as they are found in nature, while many competitors use manufactured atoms produced via electrical circuits.  Why does this matter for options? Because narrative differentiation drives institutional interest. This neutral-atom approach was validated by Google Quantum AI, which announced in March it was also pursuing neutral-atom technology for its quantum machines.  When Google validates your architecture, analysts upgrade their models, and upgraded models move options chains.
5. Relative Valuation Gives Room to Run
Infleqtion is currently trading at a $2.7 billion valuation, close to its one-year average of $2.6 billion, while IonQ is trading at $19.4 billion — well above its $15.2 billion average.  That means IonQ is stretched relative to its historical range, while INFQ is sitting near fair value with a loaded catalyst pipeline. For call buyers, you want the stock that has room to re-rate upward, not one that’s already priced for optimism.
6. Revenue Path Is More Credible Than Pure-Play Peers
INFQ benefits from government contracts in defense, sensing, and timing applications, providing more immediate revenue opportunities than pure quantum computing plays.  Infleqtion reached revenue of $32.5 million in 2025 and forecasts growth to $40 million in 2026.  That’s not nothing for a quantum company — most competitors are essentially pre-revenue science projects, which makes their options harder to underwrite fundamentally.
The Risk Side (Don’t Skip This)
INFQ is still a high-risk, high-IV name. Losses are steep, key margins run deeply negative, and letters of intent and proposals still have to become real cash before any long-term story plays out.  IV will likely be elevated right now after recent spikes, so buying calls into the move requires discipline on entry. If the CHIPS Act award gets delayed or denied, the stock could give back 30%+ fast. Position sizing accordingly.
Bottom line: INFQ sits at the intersection of a fresh IPO with no established volatility mean, a near-term binary government catalyst, technical differentiation that’s attracting institutional narrative, and a valuation that hasn’t yet stretched like its peers. For options, that’s a more interesting setup than chasing IonQ or D-Wave at elevated valuations with their catalysts already partially priced in.
Not financial advice — I’m not a financial advisor and this is for informational purposes only.
Positions